CAR T cell therapy, originally a promising treatment for cancer, is now showing potential in combating autoimmune diseases like lupus and myasthenia gravis. Researchers are excited about the ability to use this innovative approach in cases where traditional treatments have failed. Early studies suggest that CAR T cells could be effective in targeting B cell-mediated diseases, opening new avenues for patient care.
